Center-Authored Papers

Filters: Author is Hanash, Samir M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Xenograft Model Antitumor Assays
Capello M, Lee M, Wang H, Babel I, Katz MH, Fleming JB, Maitra A, Wang H, Tian W, Taguchi A et al..  2015.  Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma.. Journal of the National Cancer Institute. 107(8) Abstract
User-Computer Interface
Mathivanan S, Ahmed M, Ahn NG, Alexandre H, Amanchy R, Andrews PC, Bader JS, Balgley BM, Bantscheff M, Bennett KL et al..  2008.  Human Proteinpedia enables sharing of human protein data.. Nature biotechnology. 26(2):164-7.
Jeong S-K, Kwon M-S, Lee E-Y, Lee H-J, Cho SY, Kim H, Yoo JS, Omenn GS, Aebersold R, Hanash SM et al..  2009.  BiomarkerDigger: a versatile disease proteome database and analysis platform for the identification of plasma cancer biomarkers.. Proteomics. 9(14):3729-40. Abstract
Up-Regulation
Pitteri SJ, Faca VM, Kelly-Spratt KS, Kasarda EA, Wang H, Zhang Q, Newcomb L, Krasnoselsky A, Paczesny S, Choi G et al..  2008.  Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells.. Journal of proteome research. 7(4):1481-9. Abstract
Ubiquitin Thiolesterase
Qiu J, Choi G, Li L, Wang H, Pitteri SJ, Pereira-Faca SR, Krasnoselsky AL, Randolph TW, Omenn GS, Edelstein C et al..  2008.  Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(31):5060-6. Abstract
Tumor Suppressor Protein p53
Qiu J, Hanash SM.  2009.  Autoantibody profiling for cancer detection.. Clinics in laboratory medicine. 29(1):31-46. Abstract
Tumor Microenvironment
Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, Zhang Q, Wong C-H, Wang H, Ungewiss C, Ahn Y-H et al..  2011.  Targets of the Tumor Suppressor miR-200 in Regulation of the Epithelial-Mesenchymal Transition in Cancer.. Cancer research. 71(24):7670-7682. Abstract
Pitteri SJ, Kelly-Spratt KS, Gurley KE, Kennedy J, Busald Buson T, Chin A, Wang H, Zhang Q, Wong C-H, Chodosh LA et al..  2011.  Tumor Microenvironment-Derived Proteins Dominate the Plasma Proteome Response during Breast Cancer Induction and Progression.. Cancer research. 71(15):5090-100. Abstract
Tumor Markers, Biological
Hanash SM, Baik CS, Kallioniemi O.  2011.  Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer.. Nature reviews. Clinical oncology. 8(3):142-50. Abstract
Kim Y-S, Son OL, Lee JY, Kim SH, Oh S, Lee YS, Kim C-H, Yoo JS, Lee J-H, Miyoshi E et al..  2008.  Lectin precipitation using phytohemagglutinin-L(4) coupled to avidin-agarose for serological biomarker discovery in colorectal cancer.. Proteomics. 8(16):3229-35. Abstract
McIntosh MW, Anderson G, Drescher CW, Hanash SM, Urban ND, Brown P, Gambhir SS, Coukos G, Laird PW, Nelson B et al..  2008.  Ovarian cancer early detection claims are biased.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(22):7574;authorreply7577-9.
Pitteri SJ, JeBailey L, Faça VM, Thorpe JD, Silva MA, Ireton RC, Horton MB, Wang H, Pruitt LC, Zhang Q et al..  2009.  Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery.. PloS one. 4(11):e7916. Abstract
Hanash SM, Taguchi A.  2010.  The grand challenge to decipher the cancer proteome.. Nature reviews. Cancer. 10(9):652-60. Abstract
Hanash SM, Pitteri SJ, Faca VM.  2008.  Mining the plasma proteome for cancer biomarkers.. Nature. 452(7187):571-9. Abstract
Garcia J, Faca V, Jarzembowski J, Zhang Q, Park J, Hanash SM.  2009.  Comprehensive profiling of the cell surface proteome of Sy5Y neuroblastoma cells yields a subset of proteins associated with tumor differentiation.. Journal of proteome research. 8(8):3791-6. Abstract
Vaisocherová H, Faca VM, Taylor AD, Hanash SM, Jiang S.  2009.  Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera.. Biosensors & bioelectronics. 24(7):2143-8. Abstract
Zeng Z, Hincapie M, Haab BB, Hanash SM, Pitteri SJ, Kluck S, Hogan JM, Kennedy J, Hancock WS.  2010.  The development of an integrated platform to identify breast cancer glycoproteome changes in human serum.. Journal of chromatography. A. 1217(19):3307-15. Abstract
Taguchi A, Politi K, Pitteri SJ, Lockwood WW, Faça VM, Kelly-Spratt K, Wong C-H, Zhang Q, Chin A, Park K-S et al..  2011.  Lung cancer signatures in plasma based on proteome profiling of mouse tumor models.. Cancer cell. 20(3):289-99. Abstract
Faca V, Wang H, Hanash SM.  2009.  Proteomic global profiling for cancer biomarker discovery.. Methods in molecular biology (Clifton, N.J.). 492:309-20. Abstract
Pitteri S, Hanash SM.  2010.  A systems approach to the proteomic identification of novel cancer biomarkers.. Disease markers. 28(4):233-9. Abstract
Harsha HC, Kandasamy K, Ranganathan P, Rani S, Ramabadran S, Gollapudi S, Balakrishnan L, Dwivedi SB, Telikicherla D, Selvan LDN et al..  2009.  A compendium of potential biomarkers of pancreatic cancer.. PLoS medicine. 6(4):e1000046.
Pitteri SJ, Hanash SM.  2011.  Confounding effects of hormone replacement therapy in protein biomarker studies.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(1):134-9. Abstract
Faca VM, Song KS, Wang H, Zhang Q, Krasnoselsky AL, Newcomb LF, Plentz RR, Gurumurthy S, Redston MS, Pitteri SJ et al..  2008.  A mouse to human search for plasma proteome changes associated with pancreatic tumor development.. PLoS medicine. 5(6):e123. Abstract
Jeong S-K, Kwon M-S, Lee E-Y, Lee H-J, Cho SY, Kim H, Yoo JS, Omenn GS, Aebersold R, Hanash SM et al..  2009.  BiomarkerDigger: a versatile disease proteome database and analysis platform for the identification of plasma cancer biomarkers.. Proteomics. 9(14):3729-40. Abstract
Treatment Outcome
Capello M, Lee M, Wang H, Babel I, Katz MH, Fleming JB, Maitra A, Wang H, Tian W, Taguchi A et al..  2015.  Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma.. Journal of the National Cancer Institute. 107(8) Abstract